| Product Code: ETC067367 | Publication Date: Jul 2023 | Updated Date: Aug 2025 | Product Type: Report | |
| Publisher: 6Wresearch | Author: Ravi Bhandari | No. of Pages: 70 | No. of Figures: 35 | No. of Tables: 5 |
Indonesia paediatric genetic testing market is expected to witness a significant growth over the forecast period due to increasing prevalence of various genetic disorders, technological advancements in genomics and an increase in government funding. In addition, rising awareness among healthcare professionals related to usage of genetic testing for diagnosis & treatment decisions is driving the demand for such tests in Indonesia.
Increasing prevalence of hereditary diseases amongst infants and children; growing adoption of personalized medicine coupled with introduction of new technologies like next-generation sequencing (NGS) are major drivers fueling growth in the Indonesia paediatric genetic testing market. Moreover, increasing number of players offering different types of genomic services at competitive prices have encouraged wider adoption by end users; thus further propelling market growth.
High cost associated with advanced genetic tests as well as lack of qualified personnel in hospitals or clinical laboratories are some factors hindering growth potential during forecast period. Additionally, stringent regulations regarding sale & marketing approval from authorities further complicates already complex process thereby restraining overall market expansion during estimated timeframe.
Key companies operating within Indonesia paediatric genetic testing industry include Abbott Laboratories Inc., Eurofins Scientific SE, Illumina Inc., Bio-Rad Laboratories Inc., Agilent Technologies Inc., NeoGenomics Laboratories Inc., F Hoffmann?La Roche AG, PerkinElmer Inc., Thermo Fisher Scientific Inc., Quest Diagnostics Corporation and others. These companies hold significant share owing to their strong research capabilities and comprehensive portfolio catering customer needs across country.
The novel coronavirus pandemic has had a mixed impact on global healthcare industry including that on Indonesia paediatric diagnostic test market size; while disruption caused by lockdown measures has temporarily stalled research activities resulting into delay product launch or diminished sales revenue for few players nevertheless it has also opened up opportunities for others especially those involved in development & distribution COVID 19 detection kits etc which would aid them gain traction eventually aiding recovery post pandemic landscape.
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Indonesia Paediatric Genetic Testing Market Overview |
3.1 Indonesia Country Macro Economic Indicators |
3.2 Indonesia Paediatric Genetic Testing Market Revenues & Volume, 2020 & 2027F |
3.3 Indonesia Paediatric Genetic Testing Market - Industry Life Cycle |
3.4 Indonesia Paediatric Genetic Testing Market - Porter's Five Forces |
3.5 Indonesia Paediatric Genetic Testing Market Revenues & Volume Share, By Types, 2020 & 2027F |
3.6 Indonesia Paediatric Genetic Testing Market Revenues & Volume Share, By Applications, 2020 & 2027F |
4 Indonesia Paediatric Genetic Testing Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.3 Market Restraints |
5 Indonesia Paediatric Genetic Testing Market Trends |
6 Indonesia Paediatric Genetic Testing Market, By Types |
6.1 Indonesia Paediatric Genetic Testing Market, By Types |
6.1.1 Overview and Analysis |
6.1.2 Indonesia Paediatric Genetic Testing Market Revenues & Volume, By Types, 2018 - 2027F |
6.1.3 Indonesia Paediatric Genetic Testing Market Revenues & Volume, By Risk Assessment, 2018 - 2027F |
6.1.4 Indonesia Paediatric Genetic Testing Market Revenues & Volume, By Pharmacogenomics, 2018 - 2027F |
6.1.5 Indonesia Paediatric Genetic Testing Market Revenues & Volume, By Others, 2018 - 2027F |
6.2 Indonesia Paediatric Genetic Testing Market, By Applications |
6.2.1 Overview and Analysis |
6.2.2 Indonesia Paediatric Genetic Testing Market Revenues & Volume, By GC for Intent-to-treat Patients, 2018 - 2027F |
6.2.3 Indonesia Paediatric Genetic Testing Market Revenues & Volume, By Paediatric Care, 2018 - 2027F |
6.2.4 Indonesia Paediatric Genetic Testing Market Revenues & Volume, By Prenatal & Preconception Care, 2018 - 2027F |
7 Indonesia Paediatric Genetic Testing Market Import-Export Trade Statistics |
7.1 Indonesia Paediatric Genetic Testing Market Export to Major Countries |
7.2 Indonesia Paediatric Genetic Testing Market Imports from Major Countries |
8 Indonesia Paediatric Genetic Testing Market Key Performance Indicators |
9 Indonesia Paediatric Genetic Testing Market - Opportunity Assessment |
9.1 Indonesia Paediatric Genetic Testing Market Opportunity Assessment, By Types, 2020 & 2027F |
9.2 Indonesia Paediatric Genetic Testing Market Opportunity Assessment, By Applications, 2020 & 2027F |
10 Indonesia Paediatric Genetic Testing Market - Competitive Landscape |
10.1 Indonesia Paediatric Genetic Testing Market Revenue Share, By Companies, 2020 |
10.2 Indonesia Paediatric Genetic Testing Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here